Optima Medical Innovations Corp.
TOKIF · OTC
9/30/2021 | 6/30/2021 | 3/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.16 | 0.18 | -0.00 |
| FCF Yield | 1.25% | 5.83% | -1.65% | 8.17% |
| EV / EBITDA | -107.18 | 23.60 | 31.78 | 3.04 |
| Quality | ||||
| ROIC | -3.85% | -0.01% | -8.22% | 0.12% |
| Gross Margin | 2.07% | -3.17% | -19.11% | 36.85% |
| Cash Conversion Ratio | -0.16 | 3.91 | 1.16 | -2.57 |
| Growth | ||||
| Revenue 3-Year CAGR | -17.38% | -5.08% | 54.15% | 89.12% |
| Free Cash Flow Growth | -70.41% | 228.68% | -161.76% | 107.41% |
| Safety | ||||
| Net Debt / EBITDA | -34.22 | 9.18 | 6.92 | 1.24 |
| Interest Coverage | -1.19 | -0.01 | -2.49 | 11.89 |
| Efficiency | ||||
| Inventory Turnover | 529.84 | 451.48 | 672.05 | -402.96 |
| Cash Conversion Cycle | -57.42 | -62.11 | -33.02 | 93.32 |